Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Call Transcript

Operator: Our next question comes from the line of Drew Ranieri of Morgan Stanley. Your question please, Drew.

Drew Ranieri: Hi, thanks for taking the question. Just one on international. I think in your prepared comments, you said international ex-Japan was up 20% year-over-year. Can you maybe give us a little bit more detail about the all-in number with Japan. And then just comment on any kind of key moving drivers there in the international market. It seemed like from the acquisition call you were putting a lot of emphasis on the global reach of the two companies. So any more detail that you could share there would be great.

Keith Pfeil: Thanks for the question. So as we look at international, the Japan sales were down. There’s obviously some currency impacts in there as well. But what we really saw as we got to the back end of the quarter is touches on the stabilization that Dan commented on earlier. But as we get into 2023, we expect to start to see this business to move forward and grow.

Operator: Thank you. With no further questions, this concludes the Globus Medical Fourth Quarter and Full-Year 2022 Analyst Call. Thank you for your participation. You may now disconnect.